As of February 2026 Principia Biopharma has a market cap of NZ$5.56 Billion. This makes Principia Biopharma the world's 3889th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.